mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.00083 |
1 |
mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
-0.00099 |
1 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.00056 |
1 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.00048 |
1 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00043 |
1 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.00042 |
1 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
0.0003 |
1 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.00023 |
1 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.00026 |
1 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
0.00032 |
1 |